BioSpace News Archive

Business

AstraZeneca and Daiichi Sankyo Ink $6 Billion Cancer Pact

AstraZeneca inked a global development and commercialization deal with Daiichi Sankyo Company for DS-1062, a trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) for multiple cancer types.

July 27, 2020
·
3 min read
·
Mark Terry
Deals

Public and Private Biotech Investments Up Despite COVID-19 Slowdowns

COVID-19 put many businesses on hold, but not biotech. This sector is growing at record speeds, and only a small portion of the capital deals are related to the pandemic.

July 27, 2020
·
3 min read
·
Gail Dutton
Policy

Solid Biosciences’ DMD Gene Therapy Remains on Clinical Hold

The IGNITE DMD study is assessing the company’s microdystrophin gene therapy asset SGT-001 as a potential treatment for DMD.

July 27, 2020
·
2 min read
·
Alex Keown
Policy

Moderna Launches Phase III COVID-19 Vaccine Trial with $472 Million More in BARDA Funding

Stéphane Bancel, Moderna’s chief executive officer, stated, “We thank BARDA for this continued commitment to mRNA-1273, our vaccine candidate against COVID-19.”

July 27, 2020
·
4 min read
·
Mark Terry
Drug Development

Can a Coronavirus Vaccine Really be Ready This Year?

Ebola, HIV and Zika viruses became global challenges that caused researchers and vaccine developers to jump into action but, ultimately, vaccine development takes time. That’s why claims that SARS-CoV-2 vaccines will be available soon often are met with skepticism.

July 27, 2020
·
5 min read
·
Gail Dutton
Drug Development

T Cells May Be Critical to Understanding Immunity to COVID-19

A number of studies have suggested that people infected with COVID-19 tend to have T cells that can target the virus. However, scientists are now also realizing that some people who can test negative for COVID-19 antibodies can test positive for T cells that identify the virus within the body.

July 27, 2020
·
2 min read
·
Krystle Vermes
Policy

Pharma Industry Criticizes White House Price Control Orders

On Friday, President Donald Trump signed four executive orders in hopes of lowering prescription drug prices in the United States, which was a 2016 campaign promise.

July 27, 2020
·
3 min read
·
Alex Keown
BioCapital

Emergent BioSolutions, AstraZeneca Expand COVID-19 Vaccine Manufacturing Agreement

Gaithersburg, Maryland-based Emergent BioSolutions inked another manufacturing agreement to support the development of a vaccine against COVID-19, the disease caused by the novel coronavirus.

July 27, 2020
·
2 min read
·
Alex Keown
BioMidwest

From The Alzheimer’s Association International Conference 2020: Flu, Pneumonia Vaccinations Tied To Lower Risk Of Alzheimer’s Dementia

Flu and pneumonia vaccinations are associated with reduced risk of Alzheimer’s disease, according to new research reported at the Alzheimer’s Association International Conference® 2020.

July 27, 2020
·
7 min read
Novalis Invests in Enzyre to Support Development of Enzypad, a Breakthrough Hand-Held Diagnostic and Monitoring Device

First application allows monitoring of haemophilia patient blood coagulation status, enabling fast action to prevent or stop bleeds

July 27, 2020
·
3 min read